C07H3/02

METHOD FOR PRODUCING ALLULOSE CRYSTALS

Allulose crystals are efficiently produced from an allulose syrup using seed crystals.

AMORPHOUS MIXTURE COMPRISING A NEUTRAL MONO- OR OLIGOSACCHARIDE AND AN ACIDIC NON-CARBOHYDRATE COMPONENT

It is provided i) an amorphous carbohydrate with improved chemical stability and/or physical features, ii) a method for producing an amorphous carbohydrate with improved chemical stability and/or physical features, and iii) a method for improving the chemical stability and/or the physical features of an amorphous carbohydrate.

AMORPHOUS MIXTURE COMPRISING A NEUTRAL MONO- OR OLIGOSACCHARIDE AND AN ACIDIC NON-CARBOHYDRATE COMPONENT

It is provided i) an amorphous carbohydrate with improved chemical stability and/or physical features, ii) a method for producing an amorphous carbohydrate with improved chemical stability and/or physical features, and iii) a method for improving the chemical stability and/or the physical features of an amorphous carbohydrate.

Novel Sugar Derivatives and Uses Thereof to Prepare Novel Senolytic Agents
20230096764 · 2023-03-30 ·

Provided herein are novel sugar derivatives which are intermediates for preparing senolytic agents that selectively kill senescent cells associated with numerous pathologies and diseases, including age-related pathologies and diseases.

D-PSICOSE CRYSTAL AND PREPARATION METHOD THEREFOR

The present disclosure relates to a preparation method for a D-psicose crystal containing 98% (w/w) or more D-psicose and 0.05% (w/w) or less ethanol based on 100% (w/w) of the entire crystal. The preparation method includes a first step of mixing a D-psicose-containing solution and an organic solvent, and a second step of adding a seed to the mixed solution according to the first step and then cooling the same to obtain a massecuite containing the D-psicose crystal. Therefore, it is possible to increase the yield of the D-psicose crystal from the D-psicose crystal solution and prepare a D-psicose crystal of sufficient size and appropriate shape for use in mass production with no bad taste/smell.

D-PSICOSE CRYSTAL AND PREPARATION METHOD THEREFOR

The present disclosure relates to a preparation method for a D-psicose crystal containing 98% (w/w) or more D-psicose and 0.05% (w/w) or less ethanol based on 100% (w/w) of the entire crystal. The preparation method includes a first step of mixing a D-psicose-containing solution and an organic solvent, and a second step of adding a seed to the mixed solution according to the first step and then cooling the same to obtain a massecuite containing the D-psicose crystal. Therefore, it is possible to increase the yield of the D-psicose crystal from the D-psicose crystal solution and prepare a D-psicose crystal of sufficient size and appropriate shape for use in mass production with no bad taste/smell.

ALLULOSE CONCENTRATES IN SOLID AMORPHOUS FORM

Proposed are allulose concentrates in solid amorphous form, which are characterized in that they contain at least approximately 20 wt. % allulose, and a method for producing said concentrates.

ALLULOSE CONCENTRATES IN SOLID AMORPHOUS FORM

Proposed are allulose concentrates in solid amorphous form, which are characterized in that they contain at least approximately 20 wt. % allulose, and a method for producing said concentrates.

Compositions and methods comprising growth factors, chondroitin and glucosamine for degenerative disc regeneration

There is disclosed herein compositions, methods, uses and systems for reducing pain in a patient that emanates from a body area, preferably spine or joint. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.

Compositions and methods comprising growth factors, chondroitin and glucosamine for degenerative disc regeneration

There is disclosed herein compositions, methods, uses and systems for reducing pain in a patient that emanates from a body area, preferably spine or joint. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.